Stem Cells Market: By Product Type, By Application, Drug Discovery & Development), By Therapy Area, By Technology Type, By Cell Production, Cryopreservation, Expansion and Cell Culture), and Geography  

Stem Cells Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, Others), By Application (Regenerative Medicine (Oncology, Hematology, Orthopedics, Neurological Disorders, Cardiovascular and Myocardial Infraction, Diabetes, Injuries & Wounds, Liver Disorders, Others), Drug Discovery & Development), By Therapy Area (Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy, Syngeneic Stem Cell Therapy), By Technology Type (Cell Acquisition (Umbilical Blood Cord, Bone Marrow Harvest, Apheresis), By Cell Production (Therapeutic Cloning, In-Vitro Fertilization, Cell Culture, Isolation), Cryopreservation, Expansion and Cell Culture), and Region  

Stem Cells Market size was valued at US$ 17.12 billion by 2023 and is poised to grow at a CAGR of 8.6% from 2024 - 2030. owing to increase in prevalence of target chronic diseases and higher adoption of technological advancements coupled with rise in the economy and per capita expenditure are expected to drive the growth of the market. Moreover, rising investments in R&D owing to increased demand for stem cell production for potential investigation in disease management and cellular therapies are also recognized as the next major advancements in transforming healthcare. Additionally, Market players are expanding their cellular therapy portfolio understanding the future potential of the segment which fuels the growth of the market. However, expensive procedures for the development of stem cell therapies and regulatory complications restrain the growth of the market. Global stem cell market is surging due to increased approvals and strategic collaborations among the market players to strengthen their position different regions of the globe. For instance,

Stem Cells Market Key Developments:
  • In April 2018, Pluristem Therapeutics Inc., a developer of placenta-based stem cell products announced that the U.S.FDA has cleared the emergency use of its therapy to treat acute radiation exposure in a nuclear event.
  • In September 2017, Pluristem Therapeutics Inc. announced that the company has issued two new patients by Hong Kong Patents Registry for its cell therapy products relating to two of the company's leading indications, Critical Limb Ischemia (CLI) and muscle regeneration.

Global Stem Cells Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8.6%

Largest Market

North America

Fastest Growing Market

Europe

Stem Cells Market Dynamics

Scientists are involved in discovering novel methods in creating human stem cells owing to rising demand for the stem cell production. For instance, in March 2016, Scientists at Michigan State University unveiled new kind of cells “induced XEN cells from a cellular trash pile. These novel discoveries in stem cell therapies are recognized as the major advancements in the transformation of healthcare. Support of the government in discovering stem cells and the increase in number of stem cell banks are expected to fuel the growth of the market.

Global Stem Cells Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 17.12 billion

Market CAGR

8.6%

By Product Type

  • Adult Stem Cell
  • Human Embryonic Cell
  • Pluripotent Stem Cell
  • Others

By Application Type

  • Regenerative Medicine
  • Drug Discovery and Development

By Therapy Area

  • Autologous Stem Cell Therapy
  • Allogeneic Stem Cell Therapy
  • Syngeneic Stem Cell Therapy

By Technology Type

  • Cell Acquisition
  • Cell Production
  • Cryopreservation
  • Expansion and Sub-Culture

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

Frequently Asked Questions

The stem cells market size was valued at US$ 17.12 billion in 2023

The stem cells market key players are: Osiris Therapeutics Inc. Pluristem Therapeutics Inc. Celgene Corporation Thermo Fisher Scientific Qiagen NV Miltenyi Biotec Advanaced Cell Technology Inc. Sigma Aldrich Corporation Stem Cell Technologies Inc. Becton, Dickinson and Company AllCells LLC International Stem Cell Corporation

The stem cells market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Stem Cells Market Introduction 
2.1.Global Stem Cells Market  - Taxonomy
2.2.Global Stem Cells Market  - Definitions
2.2.1.Product Type
2.2.2.Application Type
2.2.3.Therapy Area
2.2.4.Technology Type
2.2.5.Region
3. Global Stem Cells Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Stem Cells Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Stem Cells Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Adult Stem Cell
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Human Embryonic Cell
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Pluripotent Stem Cell
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global Stem Cells Market  By Application Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Regenerative Medicine
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Drug Discovery and Development
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7. Global Stem Cells Market  By Therapy Area, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Autologous Stem Cell Therapy
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Allogeneic Stem Cell Therapy
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Syngeneic Stem Cell Therapy
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Stem Cells Market  By Technology Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Cell Acquisition
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Cell Production
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Cryopreservation
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Expansion and Sub-Culture
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Global Stem Cells Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Stem Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Adult Stem Cell
10.1.2.Human Embryonic Cell
10.1.3.Pluripotent Stem Cell
10.1.4.Others
10.2.  Application Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Regenerative Medicine
10.2.2.Drug Discovery and Development
10.3.  Therapy Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Autologous Stem Cell Therapy
10.3.2.Allogeneic Stem Cell Therapy
10.3.3.Syngeneic Stem Cell Therapy
10.4.  Technology Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Cell Acquisition
10.4.2.Cell Production
10.4.3.Cryopreservation
10.4.4.Expansion and Sub-Culture
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Stem Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Adult Stem Cell
11.1.2.Human Embryonic Cell
11.1.3.Pluripotent Stem Cell
11.1.4.Others
11.2.  Application Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Regenerative Medicine
11.2.2.Drug Discovery and Development
11.3.  Therapy Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Autologous Stem Cell Therapy
11.3.2.Allogeneic Stem Cell Therapy
11.3.3.Syngeneic Stem Cell Therapy
11.4.  Technology Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Cell Acquisition
11.4.2.Cell Production
11.4.3.Cryopreservation
11.4.4.Expansion and Sub-Culture
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Stem Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Adult Stem Cell
12.1.2.Human Embryonic Cell
12.1.3.Pluripotent Stem Cell
12.1.4.Others
12.2.  Application Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Regenerative Medicine
12.2.2.Drug Discovery and Development
12.3.  Therapy Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Autologous Stem Cell Therapy
12.3.2.Allogeneic Stem Cell Therapy
12.3.3.Syngeneic Stem Cell Therapy
12.4.  Technology Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Cell Acquisition
12.4.2.Cell Production
12.4.3.Cryopreservation
12.4.4.Expansion and Sub-Culture
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Stem Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Adult Stem Cell
13.1.2.Human Embryonic Cell
13.1.3.Pluripotent Stem Cell
13.1.4.Others
13.2.  Application Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Regenerative Medicine
13.2.2.Drug Discovery and Development
13.3.  Therapy Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Autologous Stem Cell Therapy
13.3.2.Allogeneic Stem Cell Therapy
13.3.3.Syngeneic Stem Cell Therapy
13.4.  Technology Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Cell Acquisition
13.4.2.Cell Production
13.4.3.Cryopreservation
13.4.4.Expansion and Sub-Culture
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Stem Cells Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Adult Stem Cell
14.1.2.Human Embryonic Cell
14.1.3.Pluripotent Stem Cell
14.1.4.Others
14.2.  Application Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Regenerative Medicine
14.2.2.Drug Discovery and Development
14.3.  Therapy Area Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Autologous Stem Cell Therapy
14.3.2.Allogeneic Stem Cell Therapy
14.3.3.Syngeneic Stem Cell Therapy
14.4.  Technology Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Cell Acquisition
14.4.2.Cell Production
14.4.3.Cryopreservation
14.4.4.Expansion and Sub-Culture
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Osiris Therapeutics Inc.
15.2.2.Pluristem Therapeutics Inc.
15.2.3.Celgene Corporation
15.2.4.Thermo Fisher Scientific
15.2.5.Qiagen NV
15.2.6.Miltenyi Biotec
15.2.7.Advanaced Cell Technology Inc.
15.2.8.Sigma Aldrich Corporation
15.2.9 Stem Cell Technologies Inc.
15.2.10.Becton, Dickinson and Company
15.2.11.AllCells LLC
15.2.12.International Stem Cell Corporation
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Osiris Therapeutics Inc.
  • Pluristem Therapeutics Inc.
  • Celgene Corporation
  • Thermo Fisher Scientific
  • Qiagen NV
  • Miltenyi Biotec
  • Advanaced Cell Technology Inc.
  • Sigma Aldrich Corporation
  • Stem Cell Technologies Inc.
  • Becton, Dickinson and Company
  • AllCells LLC
  • International Stem Cell Corporation

Related Industry Reports